Nel ASA (Nel, OSE: NEL) reported revenues from contracts with customers of NOK 148 million in the first quarter of 2026, down ...
Nel Hydrogen US, a subsidiary of Nel ASA (Nel, OSE:NEL), has received a purchase order from Mesure Process, a subsidiary of ...
ADAPT OCULUS is the first study to evaluate a targeted treatment for ocular MG, demonstrating that VYVGART significantly ...
The sustainable bond market has matured into a key channel for financing green and social projects. However, it has also ...
Nel ASA (Nel, OSE:NEL) will publish its first quarter 2026 report on 22 April 2026 at 07:00 CET, and will host a results ...
Sanofi and Regeneron’s Dupixent approved in the EU as the first targeted medicine to treat young children with chronic spontaneous urticaria. Approval in CSU for children two to ...
Kongsberg Gruppen ASA har i dag, 13. april 2026, avholdt ordinær generalforsamling. Alle forslag på agendaen ble vedtatt i samsvar med sty ...
Styret i Equinor ASA (OSE: EQNR, NYSE: EQNR) har i dag besluttet å foreslå for selskapets generalforsamling at selskapets aksjekapital nedsettes ved sletting av egne aksjer og innløsning av aksjer ...
Reference is made to the Annual General Meeting of Nel ASA (Nel, OSE:NEL) held today where the updated guidelines regarding ...
18:42 CEST Résultats annuels 2025 Une trajectoire de croissance rentable confirmée Eduform’Action entre dans une nouvelle phase de… ...
S&P Global Ratings has published a new Sustainability Insight assessing how the EU is recalibrating its sustainability ...
Fagron, the leading global player in pharmaceutical compounding, today publishes its quarterly results for the period ending 31 March 2026. “Our first quarter demonstrates the resilience and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results